Literature DB >> 9765443

Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections.

D M Mwaengo1, F J Novembre.   

Abstract

We have previously described the development of AIDS in a chimpanzee (C499) infected with human immunodeficiency virus type 1 (HIV-1) and the subsequent pathogenic HIV-1 infection in another chimpanzee (C455) transfused with blood from C499 (F. J. Novembre et al., J. Virol. 71:4086-4091, 1997). In the present study, two virus isolates were derived from these animals: HIV-1JC from peripheral blood mononuclear cells (PBMC) of C499, and HIV-1NC from plasma of C455. These virus isolates were used to generate two infectious molecular clones, termed HIV-1JC16 and HIV-1NC7 (JC16 and NC7, respectively). Comparative analyses of the sequences of the two clones showed that they were highly interrelated but distinct. Based on heteroduplex mobility assays, JC16 and NC7 appear to represent dominant viruses in the uncloned stock population. Compared with amino acid sequences of the parental viruses HIV-1SF2, HIV-1LAV-1b, and HIV-1NDK, JC16 and NC7 showed a number of differences, including insertions, deletions, and point mutations spread throughout the genome. However, insertion/deletion footprints in several genes of both JC16 and NC7 suggested that recombination between SF2 and LAV-1b could have occurred, possibly contributing to the generation of a pathogenic virus. Comparative in vitro analyses of the molecular clones and the uncloned stocks of HIV-1JC and HIV-1NC revealed that these viruses had strikingly similar replicative abilities in mitogen-stimulated PBMC and in macrophages. Compared to the SF2 and LAV-1b isolates of HIV-1, HIV-1JC and HIV-1NC isolates were more similar to LAV-1b with respect to the ability to replicate in mitogen-stimulated PBMC and macrophages. These viruses should prove to be useful in mapping determinants of pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765443      PMCID: PMC110315     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Human immunodeficiency virus type 1 intersubtype (B/E) recombination in a superinfected chimpanzee.

Authors:  P N Fultz; L Yue; Q Wei; M Girard
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype.

Authors:  D Bhattacharyya; B R Brooks; L Callahan
Journal:  AIDS Res Hum Retroviruses       Date:  1996-01-20       Impact factor: 2.205

Review 3.  Vaccination of chimpanzees against HIV-1.

Authors:  M Girard; F Barré-Sinoussi; E van der Ryst
Journal:  Antibiot Chemother (1971)       Date:  1996

4.  Direct demonstration of retroviral recombination in a rhesus monkey.

Authors:  D P Wooley; R A Smith; S Czajak; R C Desrosiers
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Simian immunodeficiency viruses containing mutations in the long terminal repeat NF-kappa B or Sp1 binding sites replicate efficiently in T cells and PHA-stimulated PBMCs.

Authors:  J Zhang; F Novembre; A B Rabson
Journal:  Virus Res       Date:  1997-06       Impact factor: 3.303

6.  In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.

Authors:  J D Boyer; B Wang; K E Ugen; M Agadjanyan; A Javadian; P Frost; K Dang; R A Carrano; R Ciccarelli; L Coney; W V Williams; D B Weiner
Journal:  J Med Primatol       Date:  1996-06       Impact factor: 0.667

Review 7.  The immune response: the efferent arm.

Authors:  M C Horowitz; G E Friedlaender; H Y Qian
Journal:  Clin Orthop Relat Res       Date:  1996-05       Impact factor: 4.176

8.  Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1.

Authors:  F J Novembre; M Saucier; D C Anderson; S A Klumpp; S P O'Neil; C R Brown; C E Hart; P C Guenthner; R B Swenson; H M McClure
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

Authors:  M Girard; B Meignier; F Barré-Sinoussi; M P Kieny; T Matthews; E Muchmore; P L Nara; Q Wei; L Rimsky; K Weinhold
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV-1 NDK.

Authors:  J De Mareuil; D Salaun; J C Chermann; I Hirsch
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

View more
  14 in total

1.  The HIV-1 Nef protein enhances the affinity of reverse transcriptase for RNA in vitro.

Authors:  Cécile Fournier; Jean-Claude Cortay; Caroline Carbonnelle; Chantal Ehresmann; Roland Marquet; Pierre Boulanger
Journal:  Virus Genes       Date:  2002-12       Impact factor: 2.332

2.  The evolution of HIV-1 and the origin of AIDS.

Authors:  Paul M Sharp; Beatrice H Hahn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-08-27       Impact factor: 6.237

3.  Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzees.

Authors:  F J Novembre; J de Rosayro; S Nidtha; S P O'Neil; T R Gibson; T Evans-Strickfaden; C E Hart; H M McClure
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates.

Authors:  J L Foster; R P Molina; T Luo; V K Arora; Y Huang; D D Ho; J V Garcia
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation.

Authors:  Frederic Bibollet-Ruche; Anke Heigele; Brandon F Keele; Juliet L Easlick; Julie M Decker; Jun Takehisa; Gerald Learn; Paul M Sharp; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

Review 6.  Origins of HIV and the AIDS pandemic.

Authors:  Paul M Sharp; Beatrice H Hahn
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

7.  Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.

Authors:  Kei Sato; Naoko Misawa; Junko S Takeuchi; Tomoko Kobayashi; Taisuke Izumi; Hirofumi Aso; Shumpei Nagaoka; Keisuke Yamamoto; Izumi Kimura; Yoriyuki Konno; Yusuke Nakano; Yoshio Koyanagi
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

8.  Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells.

Authors:  Youichi Suzuki; Naoko Misawa; Chihiro Sato; Hirotaka Ebina; Takao Masuda; Naoki Yamamoto; Yoshio Koyanagi
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

9.  Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee host.

Authors:  Nicola Götz; Daniel Sauter; Shariq M Usmani; Joëlle V Fritz; Christine Goffinet; Anke Heigele; Matthias Geyer; Frederic Bibollet-Ruche; Gerald H Learn; Oliver T Fackler; Beatrice H Hahn; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2012-09-13       Impact factor: 21.023

10.  Evidence for an ancient selective sweep in the MHC class I gene repertoire of chimpanzees.

Authors:  Natasja G de Groot; Nel Otting; Gaby G M Doxiadis; Sunita S Balla-Jhagjhoorsingh; Jonathan L Heeney; Jon J van Rood; Pascal Gagneux; Ronald E Bontrop
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.